公司資料
Talaris Therapeutics 股價、新聞與催化劑
- 股票代碼:
- TRML
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for TRML.
公司概覽
業務概覽
Talaris Therapeutics was a cell-therapy company focused on immune tolerance and transplant-related science before its public-market decline and restructuring. Its platform aimed to improve how cell therapy could support transplantation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Talaris sat in advanced cell therapy.
商業模式特徵
The business depended on clinical development, platform validation, and the strategic value of its immune-tolerance approach.
生技產業定位
Talaris belongs to the historical cell-therapy category rather than the current live public-company set.
未來催化劑
- Talaris is now a legacy / closeout story, so the catalysts are any residual transaction or portfolio-resolution update. There is no active standalone pipeline driving it.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。